Other inflammatory markers, such as CC-chemokine ligand 2 (CCL-2) and hyaluronic acid (HA), have also been shown to be elevated in patients with NASH [60–62]. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.